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ABSTRACT Carnitine octanoyltransferase (COT) trans-
ports medium-chain fatty acids through the peroxisome. During
isolation of a COT clone from a rat liver library, a cDNA in which
exon 2 was repeated, was characterized. Reverse transcription-
PCR amplifications of total RNAs from rat liver showed a
three-band pattern. Sequencing of the fragments revealed that,
in addition to the canonical exon organization, previously re-
ported [Choi, S. J. et al. (1995) Biochim. Biophys. Acta 1264,
215–222], there were two other forms in which exon 2 or exons
2 and 3 were repeated. The possibility of this exonic repetition in
the COT gene was ruled out by genomic Southern blot. To study
the gene expression, we analyzed RNA transcripts by Northern
blot after RNase H digestion of total RNA. Three different
transcripts were observed. Splicing experiments also were car-
ried out in vitro with different constructs that contain exon 2 plus
the 5* or the 3* adjacent intron sequences. Our results indicate
that accurate joining of two exons 2 occurs by a trans-splicing
mechanism, confirming the potential of these structures for this
process in nature. The trans-splicing can be explained by the
presence of three exon-enhancer sequences in exon 2. Analysis by
Western blot of the COT proteins by using specific antibodies
showed that two proteins corresponding to the expected Mr are
present in rat peroxisomes. This is the first time that a natural
trans-splicing reaction has been demonstrated in mammalian
cells.
In trans-splicing, two pre-mRNAs are processed to produce a
mature transcript that contains exons from both precursors. This
process is believed to proceed through two trans-esterification
steps that result in the linking of the two exons by a normal 39-59
phosphodiester bond. This process has been described mostly in
trypanosoma, nematodes, plantyalgal chloroplasts, and plant
mitochondria (1).
Trans-splicing of artificial pre-mRNAs in mammalian cells in
vitro has been reported but with some limitations (2–5). In
addition, spliced leader RNAs from nematodes or from Simian
virus 40 can be accurately trans-spliced in transfected COS cells,
which reveals functional conservation in the splicing machinery
between lower eukaryotes and mammals and demonstrated the
potential for trans-splicing in mammalian cells (6). Studies in vitro
also have shown that a synthetic pre-mRNA substrate containing
an exon and a 59 donor splice site can be efficiently trans-spliced
to another synthetic pre-mRNA (39 trans-splicing substrate) if this
contains either exonic enhancers or a downstream 59 splice site
(7–8). Several examples of possible natural trans-splicing in
mammalian cells have been reported (9–12), but none of these
trans-splicing have been demonstrated in vitro.
During our current investigation on the carnitine octanoyl-
transferase (COT) gene, that encodes for an enzyme, which
transports medium-chain fatty acids through the peroxisome, we
isolated a cDNA COT clone, which had exon 2 repeated. We
report here that the pre-mRNA of COT from rat liver produces
three different mature transcripts: one transcript produced by
cis-splicing and in addition, two transcripts produced by a trans-
splicing mechanism, in which exon 2 or exons 2 and 3 are
repeated. Western blot analysis of peroxisomal proteins using
specific antibodies showed the occurrence of two translated
proteins with molecular masses corresponding to the cis-spliced
mRNA as well as the trans-spliced mRNA in which exon 2 and
3 are repeated. To our knowledge, natural trans-splicing in which
two identical molecules of pre-mRNA produce a trans-spliced
mature mRNA has not been described in genes involved in the
metabolism of vertebrates.
MATERIALS AND METHODS
Isolation and Characterization of cDNA and Genomic Clones.
To isolate cDNA clones corresponding to COT, a lgt10 rat liver
cDNA library 59-stretch from adult male Sprague–Dawley rats
(CLONTECH) was used. To isolate genomic clones correspond-
ing to COT cDNA, a lFIX II rat genomic library Vector
(Stratagene) was used. The screenings were probed with a
fragment of 1,190 bp (XbaI–EcoRI) of plasmid l2Ax COT (13)
supplied by B. Chatterjee (University of Texas, San Antonio),
corresponding to the coding sequence from 510 to 1,700 bp of the
cDNA reported by Choi et al. (14). Hybridization was performed
in 800 mM NaCl, 20 mM Pipes (pH 6.5), 50% deionized
formamide, 0.5% SDS, and denatured salmon sperm DNA (100
mgyml). Washes was carried out in 0.1% SSC and 0,1% SDS at
65°C. The l DNAs obtained by screening from genomic and
cDNA libraries were analyzed by Southern blot. Appropriate
DNA fragments were subcloned into pBluescript for sequencing.
DNA Blot Hybridization. Total DNA from male Sprague–
Dawley rat liver was purified as described (15). Restriction
enzyme digestions, standard saline citrate transfers to Hybond-C
membrane (Amersham), hybridizations with random primed
32P-labeled probes, and filter washes were carried out according
to the manufacturer’s recommendations. Filters were autoradio-
graphed at 270°C in contact with Kodak x-ray film with an
intensifying screen.
RNase H Digestion of RNA. Total RNA from rat liver was
extracted with guanidine isothiocyanate and purified by centrif-
ugation through a CsCl cushion (16). Samples of 20 mg of total
RNA were incubated separately with oligonucleotides, E4r,
E4r-2, E5r, and E7r (Table 1) for 30 min at 37°C in a 20-ml mixture
containing 20 mM Hepes-KOH (pH 8.0), 50 mM KCl, 70 mM
MgCl2, 2 mM DTT, and 40 units of RNasin (GIBCOyBRL). The
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samples were incubated for 1 h at 30°C after addition of 0.8 units
of RNase H (Boehringer Mannheim) and then ethanol precipi-
tated. RNA was loaded onto 1.6% agarose formaldehyde gels and
transferred to NY13 nytran filters (Schleider & Shuell). Filters
were hybridized with a random primed 32P-labeled cDNA probe,
in ExpressHyb hybridization solution (CLONTECH) according
to the manufacturer’s recommendations and then autoradio-
graphed.
Reverse Transcription (RT)–PCR. The RT reaction was
performed in 200 ml of a mixture containing 10 mg of DNA-
free total RNA (in diethyl pyrocarbonate-treated water).
Either oligo dTs or random hexamers were used as primers
except for the in vitro-splicing assay, in which primers E2r-2
and I2r (see Table 1) were used. The reaction was performed
with Moloney murine leukemia virus reverse transcriptase
(GIBCOyBRL) according to the supplier’s conditions. The
incubations were at 37°C for 1 h and 95°C for 5 min. The
mixtures were then quickly chilled on ice and stored at 220°C.
PCR was performed in a total volume of 50 ml with 5 ml of
cDNAs, 1 mM of each primer, 0.2 mM dNTPs, and 1.25 mM
MgCl2. The conditions for PCR were 94°C for 30 s; 55°C for
30 s; and 72°C for 1 min for 30 cycles. The amplified fragments
were separated in agarose gels or acrylamide gels. PCR
products were sequenced with an automatic sequencer ABI
prism by using nested primers. Sequence alignments were
performed to check the identities by using the Wisconsin
Package Version 9.1, Genetics Computer Group, Madison,
WI.
Pre-mRNA Synthesis and Trans-Splicing Reaction in Vitro.
The A and B constructs were obtained by PCR amplification
by using the DNA obtained from the screening of the genomic
library as template. The purified 18-kb DNA insert (lgr5),
comprises 4.7 kb upstream from the transcription site and 13.7
kb downstream to exon 6. The nucleotides of intron 1 and
intron 2, next to exon 2, were sequenced. Using Pfu polymerase
and primers E2f and I2r or I1f and E2r-2, two fragments were
obtained. The fragments were subcloned in the EcoRV re-
striction site of pBluescript SK1 to obtain constructs A and B.
Construct A was then linearized with EcoRI. Construct B was
shortened by incubating with SacI and EcoRI, making the
extremes by blunt ending with T4 DNA polymerase and
religated (Fig. 5). Two micrograms of the plasmid A was
linearized with HindIII and transcribed in the following con-
ditions: 40 mM TriszHCl pH 7.9, 6 mM MgCl2, 10 mM NaCl,
2 mM spermidine, 10 mM DTT, 2 unitsyml RNase out
(GIBCOyBRL), 0.6 mM cap dinucleotide (GpppG), 0.5 mM
each ATP and UTP, 0.05 mM each CTP and GTP, 40 mCi
[32P]CTP (800 Ciymmol), and 2 unitsyml T7 RNA polymerase.
The incubation was performed for 60 min at 37°C. B pre-
mRNA was transcribed unlabeled in the same conditions with
the following modifications: 30 mM MgCl2, 2 unitsyml T3 RNA
polymerase, and 5 mM of each NTP. All the pre-mRNAs were
purified from a 5% (30:1) acrylamide-bisacrylamide gel (16).
In vitro trans-splicing assays (25 ml) contained 40% of HeLa
nuclear extract (17) 0.5 mM ATP, 2 mM MgCl2, 20 mM
creatine-phosphate, '5 ng (65 fmol) of radiolabeled A pre-
mRNA and increasing amounts, 10–200 ng (0.11–2.22 pmol),
of B pre-mRNA, (see Fig. 5 legend). The trans-splicing mix was
incubated for 2 h at 30°C without preincubation. Reactions
were arrested by addition of 2 ml of proteinase K (20 mgyml),
10 ml 10% SDS, 63 ml H2O, and incubated for 30 min at 37°C.
Then RNAs were extracted with phenolychloroformyisoamyl
alcohol and precipitated with ethanol. RNAs were loaded on
a denaturing 8% polyacrylamidey7 M urea gel. RNAs were
eluted from the gel and used in RT-PCR experiments.
Isolation of Rat Liver Peroxisomes. Rat liver peroxisomes were
isolated in a Nycodenz cushion as described in (18). The peroxi-
somes were dispersed in 250 mM sucrose, 10 mM TrisyHCl pH
7.4 and 1 mM EDTA and used in Western blot experiments.
Generation of Anti-Carnitine Octanoyltransferase Antibodies
and Western Blot Analysis. A peptide corresponding to the N
terminus of COT protein (sequence 43–54, ANEDEYKKTEEI)
(14) was synthesized by the solid-phase method developed by
Marglin and Merrifield (19). The peptide showed little identity to
other carnitine transferases. A cysteine residue was added to the
N-terminal end. The peptides were coupled to keyhole-limped
haemocyanin with maleimidobenzoyl-N-hydroxysuccinimide es-
ter. Two male New Zealand white rabbits were each injected s.c.
on days 0, 21, and 42 with 200 mg of the peptide coupled to
haemocyanin. The synthetic peptide-haemocyanin conjugates
were emulsified with Freund’s complete adjuvant (day 0) or
incomplete adjuvant (days 21 and 42) in a total volume of 1 ml.
Rabbits were bled from an ear vein 12 days after each booster
injection. g-Globulins from preimmune and immune sera were
purified by (NH4)2SO4 fractionation (16). The g-globulins from
peptide 43–54 were called A43. Purified peroxisomes were sub-
jected to 10% SDSyPAGE. Electroblotting to nitrocellulose
sheets was carried out for 2 h at 120 mA. Immunodetection was
performed by using anti-COT antiserum A43 and the blots were
developed by using the ECL Western blotting system from
Amersham Pharmacia Biotech.
RESULTS
Cloning and Characterization of Liver COT cDNAs. To study
different properties of the COT gene, we isolated a cDNA clone
from a rat liver cDNA library by using as a probe the XbaI--EcoRI
fragment of the reported cDNA (13). The exonic organization of
the isolated cDNA did not correspond to that reported (14);
instead, exon 2 was repeated. To rule out the possibility that the
abnormal exon 2-exon 2-exon 3, etc., organization of the isolated
clone was a product of an artifactual rearrangement and to
determine whether a trans-splicing reaction occurred naturally in
this gene, RT-PCR with different primers were carried out. The
templates for these amplifications were the cDNAs produced
after the rat liver mRNAs were reacted with reverse transcriptase
by using either oligo dTs or random hexamers as primers. Fig. 1A
Table 1. Oligonucleotides used in this study
Position Primers Orientation Sequence Expt(s)
Exon 1 E1f Sense, 22-mer 59GAG TGC AGA GAG CCA AGC CGG G39 RT-PCR
Exon 2 E2f Sense, 25-mer 59TTT TCT TAC TGT GAC TAT ACC ATG G39 RT-PCR and trans-splicing
Exon 2 E2r Antisense, 22-mer 59GGA ATG TTC GTT CTT CAA TTG A39 RT-PCR
Exon 3 E3r Antisense, 20-mer 59TGA TGC AAT GTC TTG CCA AC39 RT-PCR
Exon 4 E4r Antisense, 20-mer 59GGC GAC ATT GAG CCA CCA CT39 RT-PCR and RNase H protection
Exon 5 E5r Antisense, 18-mer 59GGT TCA TGT CTA GAG GAG39 RT-PCR and RNase H protection
Exon 7 E7r Antisense, 21-mer 59GGC CCA ACA GGT TCA TTC CAG39 RT-PCR and RNase H protection
Exon 4 E4r-2 Antisense, 21-mer 59CTT CTT AGC AGC TGC CAG TAG39 RNase H protection
Intron 2 I2r Antisense, 25-mer 59CTA CAC TAG AAG ATT ATG AAC ATA C39 Trans-splicing
Intron 1 I1f Sense, 20-mer 59CAT GGG GTG CTA AAT CCA CA39 Trans-splicing
Exon 2 E2r-2 Antisense, 22-mer 59CTG ACT CAA GGT ACT TCT TCA G39 Trans-splicing
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shows that when primers located in exon 1 and exon 3 were used
(Table 1), three different bands were visible. One of the bands
was of the expected size, but the other two were of sizes
corresponding to the inclusions of exon 2 and exons 2 and 3. The
sequencing of these bands unequivocally showed that they were
formed by (i) exon 1-exon 2-exon 2-exon 3 (390 bp) (Fig. 1C), (ii)
exon 1-exon 2-exon 3-exon 2-exon 3 (515 bp) (Fig. 1D), in addition
to the canonical cis-spliced band, and (iii) exon 1-exon 2-exon 3
(254 bp). To confirm these data, PCR amplifications were carried
out with forward primers for either exon 1 or 2 and reverse
primers complementary to exons 2, 3, 4, 5, and 7. As also shown
in Fig. 1A and B, the same three-band pattern was obtained in all
cases. Sequencing of all these bands showed that the repetition
affected only exons 2 and 3.
A possible explanation of the duplication of exons 2 and 3
in the mature transcripts was that the genomic DNA contained
duplication of exons 2 and 3. However, genomic Southern blot
showed that this is a single-copy gene and that exons 2 (Fig. 2)
and 3 (not shown) are present only once. Moreover, Southern
blot and restriction mapping of three different clones obtained
from a rat genomic library confirmed these data.
Kinetic analysis of rat mRNA levels in adult rats was
performed by RT-PCR with a variable number of cycles. The
proportion of the various bands in the PCR products starting
with exon 1 was '80%, 4%, and 16%, respectively, for the
sequence 1–2–3–4–5, 1–2–2–3–4–5, and 1–2–3–2–3–4–5 in
one experiment (Fig. 3). We studied the reproducibility of
these results and found variability in the quantitative results:
values ranging from 4% to 30% for the two bands with high
molecular mass was observed in different rats.
Detection of Three Different Size Transcripts in Rat Liver
COT. The occurrence of three different transcripts could not
be detected by Northern blot analysis of the mRNAs because
the difference in size between the three transcripts was so small
that they could not been seen separately. To improve the
sensitivity of the method and determine whether three differ-
FIG. 1. Three-band pattern obtained by RT-PCR amplification of the mRNAs of rat liver COT. PCR products were obtained by using four sets
of primers, E1f-E2r, E1f-E3r, E1f-E5r, and E1f-E7r (A) and E2f-E3r, E2f-E4r, E2f-E5r, and E2f-E7r (B). Schematic representation of the possible
origin of PCR products is shown at the top. Exons are indicated by boxes and capital letters; arrows indicate the annealing regions of the PCR primers,
lines above denote expected size for the three possible exonic organizations. Representative agarose gels of PCR products obtained with the four
sets of primers are shown at the foot of the figure. M indicates the molecular DNA markers. The size and the sequence analysis of PCR products
correspond to the exonic representation. The chromatograms show the accurate junction exon 2-exon 2 (C) and exon 3-exon 2 (D).
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ent transcripts of COT were present as independent molecules,
total RNA was hybridized with specific oligonucleotides within
different exons of the COT mRNA and digested with RNase
H, which digests double-stranded regions of RNA–DNA hy-
brids. If the trans-splicing transcripts were present, then the
treatment would result in the appearance of four different
bands detectable on a Northern blot (Fig. 4A). Using the
primers described in the legend to Fig. 4, the band of higher
molecular mass would be the most 39 and the other three of
lower molecular mass would be at the most 59 regions of the
transcripts. Fig. 4B shows a Northern blot by using the whole
cDNA COT as a probe. The results observed fit with these
predictions. Bands corresponding to the 39 fragment after
RNase H digestion (lanes 2–5) ran with a slightly faster
mobility (2,250–2,500 bp) than the uncut transcript (lane 1)
(3,000 bp). Moreover, three bands with faster mobility corre-
sponding to the 59 fragment after RNase H digestion also were
seen. The results of these analyses are consistent with the
presence of 3 transcripts of COT. The size of each fragment
corresponds to those expected.
The COT Gene Contains Natural Sequences That Were Trans-
Spliced in a Trans-Splicing Assay in Vitro with Human Nuclear
Extracts. To gain further insight into the possible role of the
sequences around exon 2 of the COT gene, two truncated
pre-mRNAs were prepared: A donor pre-mRNA, containing
FIG. 2. Southern blot analysis of genomic rat DNA. Total rat
genomic DNA, 15 mg per lane, was digested with HindIII, PstI, PvuII,
EcoRI, and NcoI. Fragments were fractionated electrophoretically,
bound on a Hybond-C membrane, and hybridized with a 32P-labeled
cDNA probe corresponding to exon 2, with positions 31–166 bp in the
cDNA sequence of rat COT (14). DNA molecular size markers are
indicated at the right.
FIG. 3. Quantification of the RT-PCR products by PCR kinetic
analysis cDNAs were obtained from total adult rat liver RNA as
described in Materials and Methods. PCR amplifications were per-
formed with E1f and E5r primers (Table 1) in the presence of 2.5 mCi
(0.25 ml) of [a-32P]dCTP (300 Ciymmol). After 20 amplification cycles,
a small portion of the PCR mix (10%), was removed every two cycles
and the products were resolved on 8% acrylamide gels. The amount
of radioactivity in each band was determined by scintillation counting.
For kinetic analysis, values of log counts per minute were plotted
against the number of cycles. The antilog of the respective intercepts
shows the proportion of each mRNA. The upper straight line denotes
the 523 pb mRNA (E), and the lower lines correspond to the 659 bp
(h) and 784 bp mRNA (). The autoradiography is shown in the Inset.
FIG. 4. RNase H Digestion of RNA. (A) The diagram shows the
products formed after binding the primer E4r to RNA and digesting
with RNase H. An analogous diagram can be formulated with the
other three primers used. (B) Total RNA from liver of adult rat was
bound in different tubes with primers E4r (exon 4), E4r-2 (exon 4), E5r
(exon 5), and E7r (exon 7) and then digested with RNase H and
analyzed on a 1.6% agarose gel with formaldehyde as described in
Materials and Methods (lanes 2–5). Lane 1 denotes control nondigested
RNA. The filter containing the transferred RNA was hybridized to a
32P-labeled cDNA probe corresponding to positions 31–1,700 bp in the
cDNA sequence from COT (14). RNA molecular size markers (M) are
indicated to the right.
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only exon 2 and the 59 splice site of intron 2 (A pre-mRNA), and
an acceptor pre-mRNA, containing the branch point region and
the 39 splice site of intron 1 and exon 2 (B pre-mRNA) (Fig. 5).
Fig. 5 also shows typical trans-splicing assays with the two
pre-mRNAs in which the donor, A pre-mRNA, was 32P-labeled
during transcription and the acceptor, B pre-mRNA, was
added unlabeled to the trans-splicing reaction. The combina-
tion of A donor with B acceptor (Fig. 5, lanes 4–8) showed that
there is a band above the pre-mRNA that is dependent on ATP
(cf. lane 2 to lanes 4–8). This band was cut, assayed by
RT-PCR, and sequenced. This band contained a correct
ligation of exon 2-exon 2, which rules out the possibility of an
alternative splice site. It turned out to be a trans-splicing
product between the A donor and the B acceptor. This product
was not seen when the B acceptor was not added to the reaction
(lane 3). The comparison of lane 2 and lanes 4–8 also shows
the occurrence of another band (exon2), which is assumed to
be one of the two intermediates of the first-step trans-splicing
reaction. This assumption is based on its size (191 nt) and on
the fact that there is a correlation between the amount of this
band and the amount of the trans-splicing product exon 2-exon
2. Lanes 4–8 also show that when the amount of receptor was
increased more product was obtained. The comparison of our
results with other trans-splicing reactions with artificial pre-
mRNAs leads us to conclude that exon 2 and the splice site
regions around it are strong trans-splicing signals and that they
may be suitable for the study of the trans-splicing mechanisms
with other genes in vitro.
Western Blot Analysis of the COT Proteins in Rat Liver
Peroxisomes. To test whether the three mature mRNAs were
translated in vivo, Western blots of peroxisomal proteins were
carried out. As observed in Fig. 6 two proteins corresponding
to 69 and 79 kDa were immunolocalized. The theoretical Mr of
the translated proteins of the cis-spliced mRNA is 70,302 Da
and that of the trans-spliced mRNA correponding to the
sequence exons 1–2–3–2–3–4 . . . , etc. is 80,572 Da, consistent
with the two proteins observed. The third trans-spliced mRNA
whose sequence is represented by 1–2–2–3–4 . . . , etc. is
expected to be translated like the cis-spliced mRNA because
the first in-frame AUG is located in the second exon 2.
DISCUSSION
In this study, we have demonstrated that the rat-liver carnitine
octanoyltransferase is a single-copy gene, which is able to be
processed in several mature transcripts involving cis- and trans-
splicing events. This has been demonstrated by different exper-
imental approaches such as screening of a cDNA library, RT-
PCR analysis, RNase H digestion, and DNA sequencing. We also
have demonstrated the ability of this mRNA to generate trans-
splicing in experiments in vitro.
The isolation of a cDNA clone containing a repeat of exon
2, could be interpreted as an artifact generated in the con-
struction of the library. However the accurate junction be-
tween the two exons 2 indicates a natural phenomenon.
Moreover, clear evidence for the occurrence of such organi-
zation came after the sequencing of the fragments obtained by
RT-PCR from total adult rat liver RNA. Not only the tran-
script composed by exon 1-exon 2-exon 2-exon 3, etc., whose
sequence was the same as the cDNA clone isolated was found,
but also the canonical exon 1-exon 2-exon 3, etc. and a third
that corresponds to exon 1-exon 2-exon 3-exon 2-exon 3-exon
4, etc. The trans-splicing episode was always produced within
exon 2 and 3 because the RT-PCR amplifications with primers
complementary to sequences of exon 4, exon 5, exon 6, exon
7, and exon 15 always produced the same three-band pattern
corresponding to an identical organization to that described
above. The possibility of the duplication of exons 2 and 3 in rat
genomic DNA was ruled out after a genomic Southern blot
experiment, which unequivocally showed that there was only
one exon 2 and one exon 3 in the genome.
Experiments with RNase H by using different annealing
primers clearly confirmed the presence of the three different
transcripts and that they were not attributable to artifacts,
suggesting the occurrence of trans-spliced mRNA molecules in
the rat liver. Splicing experiments in vitro confirmed that COT
exon 2 functions as an acceptor and as a donor in trans-splicing
reactions.
The hypothesis that trans-splicing is a regular event in mam-
malian cells was first suggested by Dandekar et al. (20). Later, the
capability of mammalian cells to perform the trans-splicing
reaction with appropriate foreign RNAs (21) also was demon-
FIG. 5. Trans-splicing of COT pre-mRNAs in vitro. Transcription
plasmids (Bluescript SK1) with the corresponding PCR fragments
were obtained as described in Materials and Methods. A Pre-mRNA
was 220 nucleotides (nt) long: 55 nt from the plasmid polylinker region
(PL) 1 exon 2 (136 nt) 1 25 nt of the 59 end of intron 2 1 4 nt PL;
B Pre-mRNA was 278 long: 23 nt PL 1 115 nt of the 39 end of intron
1 1 exon 2 (136 nt) 1 4 nt PL. BP indicates branch-point. The
32P-labeled A pre-mRNA was mixed with increasing concentrations of
unlabeled B pre-mRNA and incubated in trans-splicing conditions.
Lane 2 shows incubation reaction of labeled A pre-mRNA with 50 ng
of B pre-mRNA without ATP. Lane 3 shows the incubation reaction
with A pre-mRNA but without construct B. A pre-mRNA was
incubated with increasing amounts of B pre-mRNA (10 ng, 25 ng, 50
ng, 100 ng, and 200 ng). The trans-splicing product (AxB) (lanes 4–8)
was confirmed by RT-PCR and sequencing. The exon 2 band might
correspond to the intermediate exon 2 without the attached intron.
FIG. 6. Immunolocalization of peroxisomal COT. Ten micrograms
of rat liver peroxisomal extracts was separated by SDSyPAGE and
subjected to immunoblotting by using specific A43 antibodies (A) for
carnitine octanoyltransferase or preimmune sera (B). Two bands
corresponding approximately to Mr of 69 and 79 kDa are observed.
The markers (M) were used to determine the approximate molecular
weights of the species indicated.
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strated in vitro. The results presented here confirm this hypoth-
esis.
The mechanism responsible for the trans-splicing in lower
eukaryotic cells or mammalians cells is not well known. Solnick
(2, 4) had reported that trans-splicing in mammals in vitro can
occur only if the 59 and 39 substrate RNAs form base pairs via a
segment of complementarity in their introns. However, Konarska
et al. (3) clearly show that trans-splicing does not need comple-
mentarity in the introns. Chiara and Reed (7) agreed with this
view. Recently, reports have been published describing mamma-
lian (22) and yeast (23) trans-splicing systems by using short RNA
substrates. Bruzik and Maniatis (8) showed that the occurrence
of an exonic-splicing enhancer (ESE) in the downstream exon is
necessary for trans-splicing to occur. In addition, SR proteins
have been shown to mediate alternative splicing (24–27) and
commit pre-mRNAs to the splicing pathway (28, 29). Splicing
enhancers facilitate the assembly of protein complexes on
mRNAs containing a 39 splice site, and these complexes are
sufficiently stable to interact with 59 splice sites located on
separate mRNAs. When the sequence of exon 2 of the COT gene
is carefully examined (Fig. 7) three purine rich ESEs are detected
at positions 49 (GAAGAACGAA), 106 (GAAGAA), and 117
(GAAGAAG), which are similar to those previously described
(27). The need of these ESE to produce trans-splicing in the COT
gene remains to be demonstrated.
Conrad et al. (30, 31) demonstrated that a cis-splice acceptor
can act as a trans-splice acceptor if it is moved into a proper
context, which these authors refer to as an outron, that is, an
intron without a well defined 59 donor splice site. These studies
carried out in Caenorhabditis elegans show that when an exon of
27 nt was placed upstream of an outron it was cis-spliced at a very
low level. The trans-splicing was dominant over the cis-splicing
with a poorly defined short untranslated exon even though two
molecules are necessary for trans-splicing to occur. This is ap-
parently the case shown here. The short, untranslated, poorly
defined exon 1 with 30 nt (32) may not be long enough to define
the intron 1, and it becomes outron-like, which allows trans-
splicing and cis-splicing to take place, simultaneously.
From this study, it is clear that a trans-splicing occurs in the rat
liver mRNAs when the processing of the pre-mRNAs takes place.
Trans-splicing in the COT gene may occur as a result of the
following: (i) the presence of several ESEs in exon 2, (ii) the
strength of the 39 acceptor splice site, and (iii) the poorly defined
exon 1 with only 30 nt.
The Western blot experiment revealed the presence in
peroxisomes of two proteins translated from the mRNAs
generated by cis- and trans-splicing. In theory only two pro-
teins should be expected to appear. One, of 70,302 Da would
correspond to the cis-spliced exon 1-exon 2-exon 3 . . . , etc.
mRNA, which is indistinguishable from the protein translated
from the trans-spliced form exon 1-exon 2-exon 2-exon 3 . . . ,
etc. mRNA, as exon 1 is before the first AUG codon and the
first exon 2 is out of frame with respect to the second exon 2
and the following exons. The second protein (Mr 80, 572 Da),
translated from the trans-spliced mRNA composed by exons
1–2–3–2–3–4 . . . , etc. should also appear. As seen in Fig. 6, two
proteins with molecular mass of 69 and 79 kDa were clearly
seen in the immunoblot of peroxisomal proteins when we used
specific antibodies against a selected hydrophilic peptide of
COT. The occurrence of the two forms of the COT enzyme in
peroxisomes may be a direct consequence of this trans-splicing
mechanism in the COT gene.
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FIG. 7. Model for cis- and trans-splicing in COT pre-mRNA. The
exons are represented by boxes and the introns by dotted lines.
Sequences of the 59- and 39-intronic splice sites are indicated in
lowercase. The ESE are represented in exon 2 in capital letters.
Simultaneous cis- and trans-splicing of hepatic mRNA COT are
produced. Trans-splicing can be promoted by ESE sequences. The 39
acceptor site of intron 1 reacts with the 59 donor sites of introns 2 or
3 of other molecules of pre-mRNA (trans-splicing). The organization
of the mRNAs is shown at the foot.
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